Emcure Pharma

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE168P01015
NSEID: EMCURE
BSEID: 544210
View on NSE | View on BSE

INR

1,547.60

-42.5 (-2.67%)

BSENSE

Apr 02

BSE+NSE Vol: 4.35 lacs

{
  "main_header": {
    "sid": 10039308,
    "name": "Emcure Pharma",
    "stock_name": "Emcure Pharma",
    "full_name": "Emcure Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/emcure-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,547.60",
    "chg": -42.5,
    "chgp": "-2.67%",
    "dir": -1,
    "prev_price": "1,590.10",
    "mcapval": "28,868.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544210,
    "symbol": "EMCURE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE168P01015",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "4.35 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/emcure-pharma-10039308-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Emcure Pharmaceuticals Ltd Hits Intraday Low Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-hits-intraday-low-amid-price-pressure-3930330",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/EmcurePharmaceu_priceRelatedfactors_3930330.png",
        "date": "2026-04-02 10:31:11",
        "description": "Emcure Pharmaceuticals Ltd experienced a notable decline today, touching an intraday low of Rs 1467.6, reflecting a 7.62% drop as the stock faced significant price pressure amid a broadly negative market environment and sectoral weakness."
      },
      {
        "title": "Emcure Pharmaceuticals Downgraded to Hold Amid Valuation Concerns Despite Strong Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-downgraded-to-hold-amid-valuation-concerns-despite-strong-financials-3929723",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/EmcurePharmaceu_mojoScore_3929723.png",
        "date": "2026-04-02 08:37:33",
        "description": "Emcure Pharmaceuticals Ltd has seen its investment rating downgraded from Buy to Hold as of 1 April 2026, reflecting a nuanced assessment of its quality, valuation, financial trend, and technical parameters. Despite robust quarterly financial results and strong institutional interest, concerns over valuation and long-term growth prospects have tempered enthusiasm among analysts."
      },
      {
        "title": "Emcure Pharmaceuticals Surges 11.92%: 6 Key Factors Driving the Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-surges-1192-6-key-factors-driving-the-rally-3921234",
        "imagepath": "",
        "date": "2026-03-28 10:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>23 Mar:</strong> Stock dips 0.40% amid broad market sell-off</p>\n                    <p><strong>24 Mar:</strong> Strong rebound with 4.62% gain on positive sector cues</p>\n                    <p><strong>25 Mar:</strong> New 52-week and all-time highs at Rs.1,620 and Rs.1,599.95 respectively; rating upgraded to Buy</p>\n                    <p><strong>27 Mar:</strong> Hits fresh 52-week high at Rs.1,672.65 and all-time high price; technical momentum shifts bullish</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,477.45</div></div>\n                    <div ..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Emcure Pharmaceuticals Ltd to 52-Week High of Rs 1672.65",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-hits-new-52-week-high-at-rs167265-3919475",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EmcurePharmaceu_priceRelatedfactors_3919475.png",
        "date": "2026-03-27 12:16:01",
        "description": "Surging past its previous peaks, Emcure Pharmaceuticals Ltd touched a new 52-week high of Rs 1672.65 on 27 Mar 2026, marking a significant milestone in its price momentum. This breakout comes amid a three-day consecutive gain that has propelled the stock up by 11.31%, outpacing its sector by 3.05% on the day."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Hits All-Time High of Rs 1,627.50 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-stock-hits-all-time-high-on-27-mar-2026-3918827",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EmcurePharmaceu_priceRelatedfactors_3918827.png",
        "date": "2026-03-27 10:08:03",
        "description": ""
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-3918563",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EmcurePharmaceu_technicaldot_3918563.png",
        "date": "2026-03-27 08:03:22",
        "description": "Emcure Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, moving from a mildly bullish to a bullish technical trend, supported by a confluence of positive signals across key indicators such as moving averages, Bollinger Bands, and Dow Theory. This technical evolution coincides with a robust price performance that outpaces the broader market, signalling renewed investor confidence in this small-cap pharmaceutical player."
      },
      {
        "title": "Emcure Pharmaceuticals Upgraded to Buy on Strong Technical and Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-upgraded-to-buy-on-strong-technical-and-financial-performance-3917704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EmcurePharmaceu_mojoScore_3917704.png",
        "date": "2026-03-26 08:16:33",
        "description": "Emcure Pharmaceuticals Ltd has seen its investment rating upgraded from Hold to Buy, reflecting significant improvements across technical indicators, financial performance, valuation metrics, and overall quality. This upgrade, effective from 25 March 2026, is underpinned by a robust technical trend, strong quarterly results, and favourable market returns that outpace benchmarks, signalling renewed investor confidence in the small-cap pharmaceutical firm."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Emcure Pharmaceuticals Ltd to 52-Week High of Rs 1620",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-hits-new-52-week-high-at-rs1620-3916045",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EmcurePharmaceu_priceRelatedfactors_3916045.png",
        "date": "2026-03-25 10:50:36",
        "description": "With a decisive surge to Rs 1620 on 25 Mar 2026, Emcure Pharmaceuticals Ltd has reached a fresh 52-week high, extending its impressive 57.18% rally over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained outperformance relative to the broader market."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Hits All-Time High of Rs 1,599.95 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-stock-hits-all-time-high-at-rs159995-3915972",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EmcurePharmaceu_priceRelatedfactors_3915972.png",
        "date": "2026-03-25 10:14:48",
        "description": ""
      }
    ],
    "total": 379,
    "sid": "10039308",
    "stock_news_url": "https://www.marketsmojo.com/news/emcure-pharmaceuticals-10039308"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Emcure Pharmaceuticals Ltd has declared <strong>30%</strong> dividend, ex-date: 14 Aug 25",
          "dt": "2025-08-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Emcure Pharmaceuticals Ltd Hits Intraday Low Amid Price Pressure

2026-04-02 10:31:11

Emcure Pharmaceuticals Ltd experienced a notable decline today, touching an intraday low of Rs 1467.6, reflecting a 7.62% drop as the stock faced significant price pressure amid a broadly negative market environment and sectoral weakness.

Read full news article

Emcure Pharmaceuticals Downgraded to Hold Amid Valuation Concerns Despite Strong Financials

2026-04-02 08:37:33

Emcure Pharmaceuticals Ltd has seen its investment rating downgraded from Buy to Hold as of 1 April 2026, reflecting a nuanced assessment of its quality, valuation, financial trend, and technical parameters. Despite robust quarterly financial results and strong institutional interest, concerns over valuation and long-term growth prospects have tempered enthusiasm among analysts.

Read full news article

Emcure Pharmaceuticals Surges 11.92%: 6 Key Factors Driving the Rally

2026-03-28 10:00:05

Key Events This Week

23 Mar: Stock dips 0.40% amid broad market sell-off

24 Mar: Strong rebound with 4.62% gain on positive sector cues

25 Mar: New 52-week and all-time highs at Rs.1,620 and Rs.1,599.95 respectively; rating upgraded to Buy

27 Mar: Hits fresh 52-week high at Rs.1,672.65 and all-time high price; technical momentum shifts bullish

Week Open

Rs.1,477.45

Read full news article

Broad-Based Technical Strength Lifts Emcure Pharmaceuticals Ltd to 52-Week High of Rs 1672.65

2026-03-27 12:16:01

Surging past its previous peaks, Emcure Pharmaceuticals Ltd touched a new 52-week high of Rs 1672.65 on 27 Mar 2026, marking a significant milestone in its price momentum. This breakout comes amid a three-day consecutive gain that has propelled the stock up by 11.31%, outpacing its sector by 3.05% on the day.

Read full news article

Emcure Pharmaceuticals Ltd Hits All-Time High of Rs 1,627.50 as Momentum Builds Across Timeframes

2026-03-27 10:08:03

Read full news article

Emcure Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-03-27 08:03:22

Emcure Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, moving from a mildly bullish to a bullish technical trend, supported by a confluence of positive signals across key indicators such as moving averages, Bollinger Bands, and Dow Theory. This technical evolution coincides with a robust price performance that outpaces the broader market, signalling renewed investor confidence in this small-cap pharmaceutical player.

Read full news article

Emcure Pharmaceuticals Upgraded to Buy on Strong Technical and Financial Performance

2026-03-26 08:16:33

Emcure Pharmaceuticals Ltd has seen its investment rating upgraded from Hold to Buy, reflecting significant improvements across technical indicators, financial performance, valuation metrics, and overall quality. This upgrade, effective from 25 March 2026, is underpinned by a robust technical trend, strong quarterly results, and favourable market returns that outpace benchmarks, signalling renewed investor confidence in the small-cap pharmaceutical firm.

Read full news article

Broad-Based Technical Strength Lifts Emcure Pharmaceuticals Ltd to 52-Week High of Rs 1620

2026-03-25 10:50:36

With a decisive surge to Rs 1620 on 25 Mar 2026, Emcure Pharmaceuticals Ltd has reached a fresh 52-week high, extending its impressive 57.18% rally over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained outperformance relative to the broader market.